FlexPac to expand into pharma after Blackard acquisition

The acquisition of Flexible Packaging (FlexPac) of the US by the Blackard Group will spur the development of the company's technology into new industrial sectors, including pharmaceuticals.

FlexPac is a printer/converter of flexible packaging films and substrates that to date has focused its efforts mainly in the nutraceuticals arena. Now, Blackard intends to adapt its technologies for other applications, including pharmaceuticals and food packaging, according to the company's director of sales, Jack Thrasher.

FlexPac provides up to 8-color printing on its narrow-web flexographic presses, printing on a wide variety of materials, including laminated paper, metallised polyester and others. In most cases, FlexPac ships printed rolls to co-packers which convert the rolls into bags and pouches.

The Blackard Group says it will maintain FlexPac's manufacturing facility in St. Louis, and establish a sales office in Galveston, Texas

"FlexPac offers the marketplace an alternative to rigid packaging," says Michael Nixon, Blackard Group executive vice president. "We plan to expand that niche."

The Blackard Group started out as a reasl estate development company formed by Jeffory Blackard, but latterly has made investments in a variety of manufacturing and technology companies.